Barely Significant
← all excerpts

Combined Hesperidin and Gemcitabine Therapy Modulates Apoptosis and Angiogenesis Pathways in ISHIKAWA Human Endometrial Adenocarcinoma Cells.

Medicina (Kaunas) · 2025 · PMC12471335 · PMID 41010990

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantp < 0.01actually significant
Importantly, the combination of Hes and Gem produced the most pronounced reduction in VEGF secretion, with a highly significant decrease relative to both the untreated control and the single-agent treatments ( p < 0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.